Przybyl, CEO and President of ANI Pharmaceuticals, mentioned, This acquisition further expands our near-term generic pipeline. We plan to re-launch the product within the next 12 months. We are excited that transaction further extends the ANI-Teva relationship. ANI offers forty-seven generic drug products under development addressing a total annual market size of around $3.0 billion, predicated on data from IMS Health.. ANI acquires approved ANDA for Flecainide Acetate tablets USP ANI Pharmaceuticals, Inc. today announced that it has acquired the approved abbreviated brand-new drug program for Flecainide Acetate tablets USP 50mg, 100mg and 150mg, marketed simply by Teva Pharmaceuticals previously.They learn to consider their personal experiences and pay it ahead to raised their community. The Life Beyond Cancer Basis appreciates the early dedication of American Express as a Silver Sponsor and CURE magazine as its press sponsor. Because of these generous sponsors, the 2010 Life Beyond Tumor Retreat is offered at the extremely discounted rate of $200. This price covers the entire 4-day program and includes everything from board and room to lectures and activities. Participants, however, are in charge of their travel costs. Oncology and other medical practices are encouraged to sponsor patients, survivors, nurses, social employees and physicians as suitable. Survivors and Patients who would like to attend, but have limited funds may make an application for scholarships on the web at The deadline for applications is usually September 1.